昂利康(002940)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002940 昂利康

交易中 08-21 11:27:06

{"stockData":{"symbol":"002940","market":"SZ","secType":"STK","nameCN":"昂利康","latestPrice":12.6,"timestamp":1724210826000,"preClose":12.45,"halted":0,"volume":763200,"delay":0,"floatShares":185000000,"shares":202000000,"eps":0.5925,"marketStatus":"交易中","marketStatusCode":2,"change":0.15,"latestTime":"08-21 11:27:06","open":12.45,"high":12.65,"low":12.25,"amount":9567300,"amplitude":0.0321,"askPrice":12.61,"askSize":3,"bidPrice":12.6,"bidSize":48,"shortable":0,"etf":0,"ttmEps":0.5925,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1724211000000},"adr":0,"adjPreClose":12.45,"symbolType":"stock","openAndCloseTimeList":[[1724203800000,1724211000000],[1724216400000,1724223600000]],"highLimit":13.7,"lowLimit":11.21,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":201728186,"pbRate":1.57,"roa":"--","roe":"1.77%","epsLYR":0.69,"committee":-0.60815,"marketValue":2542000000,"floatMarketCap":2334000000,"peRate":21.265824,"changeRate":0.012,"turnoverRate":0.0041,"status":0},"requestUrl":"/m/hq/s/002940","defaultTab":"news","newsList":[{"id":"2459942951","title":"昂利康（002940）8月13日主力资金净买入70.20万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459942951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459942951?lang=zh_cn&edition=full","pubTime":"2024-08-13 15:25","pubTimestamp":1723533944,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月13日收盘，昂利康报收于12.59元，下跌1.1%，换手率1.1%，成交量2.03万手，成交额2558.8万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：昂利康2024年一季报显示，公司主营收入4.08亿元，同比下降3.89%；归母净利润2821.87万元，同比下降40.05%；扣非净利润2158.87万元，同比下降32.33%；负债率40.37%，投资收益-220.61万元，财务费用-379.4万元，毛利率39.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300025267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"gpt_icon":0},{"id":"2458790532","title":"昂利康（002940）8月9日主力资金净卖出91.12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458790532","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458790532?lang=zh_cn&edition=full","pubTime":"2024-08-09 15:26","pubTimestamp":1723188395,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月9日收盘，昂利康报收于12.51元，下跌2.95%，换手率1.89%，成交量3.51万手，成交额4441.45万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：昂利康2024年一季报显示，公司主营收入4.08亿元，同比下降3.89%；归母净利润2821.87万元，同比下降40.05%；扣非净利润2158.87万元，同比下降32.33%；负债率40.37%，投资收益-220.61万元，财务费用-379.4万元，毛利率39.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080900025894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"gpt_icon":0},{"id":"2457402354","title":"昂利康（002940）8月8日主力资金净买入210.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457402354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457402354?lang=zh_cn&edition=full","pubTime":"2024-08-08 15:21","pubTimestamp":1723101689,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月8日收盘，昂利康报收于12.89元，上涨2.22%，换手率2.6%，成交量4.82万手，成交额6228.06万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：昂利康2024年一季报显示，公司主营收入4.08亿元，同比下降3.89%；归母净利润2821.87万元，同比下降40.05%；扣非净利润2158.87万元，同比下降32.33%；负债率40.37%，投资收益-220.61万元，财务费用-379.4万元，毛利率39.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800025077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"gpt_icon":0},{"id":"2457604614","title":"昂利康最新公告：合作产品碳酸镧咀嚼片获得药品注册批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2457604614","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457604614?lang=zh_cn&edition=full","pubTime":"2024-08-06 20:01","pubTimestamp":1722945669,"startTime":"0","endTime":"0","summary":"昂利康公告，近日，公司收到合作方北京美福润医药科技股份有限公司通知，公司与其全资子公司温州海鹤药业有限公司合作研发的碳酸镧咀嚼片获得国家药品监督管理局的药品注册批准。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080600039489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"gpt_icon":0},{"id":"2457904817","title":"昂利康最新公告：获得聚卡波非钙片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2457904817","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457904817?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:31","pubTimestamp":1722943868,"startTime":"0","endTime":"0","summary":"昂利康公告，公司收到国家药监局签发的聚卡波非钙片（0.5g）《药品注册证书》，该药品用于缓解肠易激综合征（便秘型）患者的便秘症状。公司于2023年1月获得该药品上市许可申请受理通知书，近日获得国家药监局批准。此次获得药品注册证书将进一步丰富公司产品管线。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080600038104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"gpt_icon":0},{"id":"2457488450","title":"【昂利康(002940.SZ)：聚卡波非钙片获得药品注册证书】智通财经APP讯，昂利康(002940.SZ)发布公告，近日，公司收到国家药品监督管理局签发的聚卡波非钙片(0.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457488450","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457488450?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:25","pubTimestamp":1722943532,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0239","002940"],"gpt_icon":0},{"id":"2457048825","title":"昂利康(002940.SZ)：聚卡波非钙片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2457048825","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457048825?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:25","pubTimestamp":1722943532,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昂利康(002940.SZ)发布公告，近日，公司收到国家药品监督管理局签发的聚卡波非钙片(0.5g)《药品注册证书》，聚卡波非钙片用于缓解肠易激综合征(便秘型)患者的便秘症状。本次聚卡波非钙片获得药品注册证书，将进一步丰富公司产品管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1160718.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002940"],"gpt_icon":0},{"id":"2457901029","title":"【昂利康(002940.SZ)合作产品碳酸镧咀嚼片获得药品注册批准】智通财经APP讯，昂利康(002940.SZ)发布公告，近日，公司收到合作方北京美福润医药科技股份有限公司(简称“美福润”)通知，公司与其全资子公司温州海鹤药业有限公司(简称“海鹤药业”)合作研发的碳酸镧咀嚼片获得国家药品监督管理局的药品注册批准。","url":"https://stock-news.laohu8.com/highlight/detail?id=2457901029","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457901029?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:23","pubTimestamp":1722943427,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159938","BK1161","BK1574","BK0239","002940","BK1515","09939"],"gpt_icon":0},{"id":"2457010450","title":"昂利康(002940.SZ)合作产品碳酸镧咀嚼片获得药品注册批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2457010450","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457010450?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:23","pubTimestamp":1722943427,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昂利康 发布公告，近日，公司收到合作方北京美福润医药科技股份有限公司通知，公司与其全资子公司温州海鹤药业有限公司合作研发的碳酸镧咀嚼片获得国家药品监督管理局的药品注册批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1160716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["002940","BK0239"],"gpt_icon":0},{"id":"2455927974","title":"昂利康（002940）7月31日主力资金净买入95.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455927974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455927974?lang=zh_cn&edition=full","pubTime":"2024-07-31 15:24","pubTimestamp":1722410690,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月31日收盘，昂利康报收于12.55元，上涨5.55%，换手率1.71%，成交量3.18万手，成交额3923.0万元。昂利康主营业务：主要从事的业务为医药的生产制造业务,主要包括化学原料药、化学制剂、药用辅料及特色中间体系列产品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100027190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"gpt_icon":0},{"id":"2455994652","title":"高血压概念盘中拉升，昂利康涨2.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455994652","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455994652?lang=zh_cn&edition=full","pubTime":"2024-07-31 10:02","pubTimestamp":1722391326,"startTime":"0","endTime":"0","summary":"07月31日，高血压概念盘中拉升，截至10点02分，高血压概念整体指数上涨1.00%，报906.680点。从个股上来看，该概念的成分股中，昂利康涨2.52%，立方制药、华海药业、吉贝尔涨幅居前。从资金上来看，截止发稿，高血压概念主力净流入为-894.53万，其中华海药业受到资金热捧，主力净流入207.62万；拉长时间线来看，该板块近20日主力资金净流入-3.94亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731100206aefc4f16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731100206aefc4f16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600521","BK0012","BK0028","BK0188","BK0201","BK0185","BK0239","002940","BK0070"],"gpt_icon":0},{"id":"2455682008","title":"昂利康（002940）7月29日主力资金净卖出688.66万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455682008","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455682008?lang=zh_cn&edition=full","pubTime":"2024-07-29 15:23","pubTimestamp":1722237816,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月29日收盘，昂利康报收于11.98元，下跌2.44%，换手率1.12%，成交量2.07万手，成交额2503.69万元。昂利康主营业务：主要从事的业务为医药的生产制造业务,主要包括化学原料药、化学制剂、药用辅料及特色中间体系列产品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072900016172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"gpt_icon":0},{"id":"2453701283","title":"昂利康（002940）7月23日主力资金净卖出13.50万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453701283","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453701283?lang=zh_cn&edition=full","pubTime":"2024-07-23 15:29","pubTimestamp":1721719771,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月23日收盘，昂利康报收于12.47元，下跌4.88%，换手率2.17%，成交量4.02万手，成交额5108.98万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：昂利康2024年一季报显示，公司主营收入4.08亿元，同比下降3.89%；归母净利润2821.87万元，同比下降40.05%；扣非净利润2158.87万元，同比下降32.33%；负债率40.37%，投资收益-220.61万元，财务费用-379.4万元，毛利率39.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300023722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002940"],"gpt_icon":0},{"id":"2453737678","title":"昂利康（002940）7月22日主力资金净卖出171.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453737678","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453737678?lang=zh_cn&edition=full","pubTime":"2024-07-22 15:22","pubTimestamp":1721632977,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月22日收盘，昂利康报收于13.11元，下跌3.18%，换手率2.23%，成交量4.14万手，成交额5400.88万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：昂利康2024年一季报显示，公司主营收入4.08亿元，同比下降3.89%；归母净利润2821.87万元，同比下降40.05%；扣非净利润2158.87万元，同比下降32.33%；负债率40.37%，投资收益-220.61万元，财务费用-379.4万元，毛利率39.74%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200013641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"gpt_icon":0},{"id":"2451254615","title":"【昂利康(002940.SZ)：头孢氨苄胶囊通过仿制药一致性评价】智通财经APP讯，昂利康(002940.SZ)公告，公司收到国家药品监督管理局(简称“国家药监局”)签发的头孢氨苄胶囊(0.","url":"https://stock-news.laohu8.com/highlight/detail?id=2451254615","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451254615?lang=zh_cn&edition=full","pubTime":"2024-07-15 16:49","pubTimestamp":1721033396,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0239","002940"],"gpt_icon":0},{"id":"2451154426","title":"昂利康(002940.SZ)：头孢氨苄胶囊通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2451154426","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451154426?lang=zh_cn&edition=full","pubTime":"2024-07-15 16:49","pubTimestamp":1721033396,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昂利康(002940.SZ)公告，公司收到国家药品监督管理局(简称“国家药监局”)签发的头孢氨苄胶囊(0.125g、0.25g)《药品补充申请批准通知书》，该药品已通过仿制药质量和疗效一致性评价。据悉，头孢氨苄胶囊适用于敏感菌所致的急性扁桃体炎、咽峡炎、鼻窦炎、支气管炎、肺炎等呼吸道感染、中耳炎、尿路感染及皮肤软组织感染等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150926.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002940"],"gpt_icon":0},{"id":"2451615945","title":"昂利康：收到国家药品监督管理局签发的头孢氨苄胶囊（0.125g、0.25g）《药品补充申请批准通知书》，该药品已通过仿制药质量和疗效一致性评价。","url":"https://stock-news.laohu8.com/highlight/detail?id=2451615945","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451615945?lang=zh_cn&edition=full","pubTime":"2024-07-15 16:47","pubTimestamp":1721033234,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["002940","BK0239"],"gpt_icon":0},{"id":"2450096392","title":"昂利康（002940）7月9日主力资金净买入175.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450096392","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450096392?lang=zh_cn&edition=full","pubTime":"2024-07-09 15:25","pubTimestamp":1720509928,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月9日收盘，昂利康报收于13.44元，下跌1.25%，换手率1.64%，成交量3.04万手，成交额4057.13万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：昂利康2024年一季报显示，公司主营收入4.08亿元，同比下降3.89%；归母净利润2821.87万元，同比下降40.05%；扣非净利润2158.87万元，同比下降32.33%；负债率40.37%，投资收益-220.61万元，财务费用-379.4万元，毛利率39.74%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070900027019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002940","BK0239"],"gpt_icon":0},{"id":"2449720804","title":"昂利康(002940.SZ)获得沙库巴曲缬沙坦钠片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2449720804","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449720804?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:17","pubTimestamp":1720433871,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昂利康(002940.SZ)发布公告，近日，公司收到国家药品监督管理局(“国家药监局”)签发的沙库巴曲缬沙坦钠片(200mg)《药品注册证书》。本次获得《药品注册证书》视同通过一致性评价。据悉，沙库巴曲缬沙坦钠片是治疗慢性心力衰竭药物，用于射血分数降低的慢性心力衰竭的成人患者和用于治疗原发性高血压。该产品系公司与苏州鹏旭医药科技有限公司、苏州晶云药物科技股份有限公司共同合作研发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147081.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002940"],"gpt_icon":0},{"id":"2449272038","title":"【昂利康(002940.SZ)获得沙库巴曲缬沙坦钠片药品注册证书】智通财经APP讯，昂利康(002940.SZ)发布公告，近日，公司收到国家药品监督管理局(“国家药监局”)签发的沙库巴曲缬沙坦钠片(200mg)《药品注册证书》。","url":"https://stock-news.laohu8.com/highlight/detail?id=2449272038","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449272038?lang=zh_cn&edition=full","pubTime":"2024-07-08 18:17","pubTimestamp":1720433871,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["002940","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2018-10-23","address":"浙江省绍兴市嵊州市嵊州大道北1000号","stockEarnings":[{"period":"1week","weight":-0.0111},{"period":"1month","weight":-0.0805},{"period":"3month","weight":-0.2784},{"period":"6month","weight":-0.192},{"period":"1year","weight":-0.2906},{"period":"ytd","weight":-0.4187}],"companyName":"浙江昂利康制药股份有限公司","boardCode":"AI0027","perCapita":"19855股","boardName":"医药制造业","registeredCapital":"20172万元","compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0388},{"period":"3month","weight":-0.0924},{"period":"6month","weight":-0.0407},{"period":"1year","weight":-0.0732},{"period":"ytd","weight":-0.0364}],"survey":"　　浙江昂利康制药股份有限公司主要从事医药生产制造业务，主要包括化学原料药、化学制剂和药用辅料的研发、生产和销售。主要产品包括口服头孢类抗生素原料药（包括头孢氨苄、头孢拉定和头孢克洛）和alpha酮酸原料药等原料药品种、抗感染类制剂（包括头孢克肟胶囊、头孢克洛缓释片和头孢克洛颗粒等）、心血管类制剂（包括苯磺酸左氨氯地平片、硝苯地平缓释片等）、明胶空心胶囊。公司为高新技术企业，公司研发中心被浙江省科学技术厅认定为省级高新技术企业研究开发中心、省重点企业研究院，并设有院士专家工作站和外国专家工作站。","serverTime":1724210844361,"listedPrice":23.07,"stockholders":"9331人(较上一季度增加0.97%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昂利康(002940)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昂利康(002940)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昂利康,002940,昂利康股票,昂利康股票老虎,昂利康股票老虎国际,昂利康行情,昂利康股票行情,昂利康股价,昂利康股市,昂利康股票价格,昂利康股票交易,昂利康股票购买,昂利康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昂利康(002940)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昂利康(002940)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}